Sudden death due to cardiac arrhythmias.

This review article summarizes important changes in our approach to the serious public health problem of sudden death from ventricular arrhythmias.

[1]  L. Cobb,et al.  Survival after Resuscitation from Out‐of‐Hospital Ventricular Fibrillation , 1974, Circulation.

[2]  J J Heger,et al.  Sudden cardiac death. , 1998, Circulation.

[3]  J. Goldberg,et al.  Ventricular Premature Complexes and Sudden Death After Myocardial Infarction , 1981, Circulation.

[4]  J. Fleiss,et al.  Risk stratification and survival after myocardial infarction. , 1983, The New England journal of medicine.

[5]  P. Brugada,et al.  Significance of ventricular arrhythmias initiated by programmed ventricular stimulation: the importance of the type of ventricular arrhythmia induced and the number of premature stimuli required. , 1984, Circulation.

[6]  J P Miller,et al.  The relationships among ventricular arrhythmias, left ventricular dysfunction, and mortality in the 2 years after myocardial infarction. , 1984, Circulation.

[7]  R. Peto,et al.  Beta blockade during and after myocardial infarction: an overview of the randomized trials. , 1985, Progress in cardiovascular diseases.

[8]  D. Waters,et al.  Programmed ventricular stimulation in survivors of an acute myocardial infarction. , 1985, Circulation.

[9]  M. Eldar,et al.  Electrophysiologic testing and follow-up of patients with aborted sudden death. , 1987, Journal of the American College of Cardiology.

[10]  J. Miller,et al.  Decreased heart rate variability and its association with increased mortality after acute myocardial infarction. , 1987, The American journal of cardiology.

[11]  S L Winters,et al.  A new noninvasive index to predict sustained ventricular tachycardia and sudden death in the first year after myocardial infarction: based on signal-averaged electrocardiogram, radionuclide ejection fraction and Holter monitoring. , 1987, Journal of the American College of Cardiology.

[12]  R J Cohen,et al.  Electrical alternans and cardiac electrical instability. , 1988, Circulation.

[13]  E. Prystowsky.  Electrophysiologic‐Electropharmacologic Testing in Patients With Ventricular Arrhythmias , 1988, Pacing and clinical electrophysiology : PACE.

[14]  W. Stevenson,et al.  Diverse mechanisms of unexpected cardiac arrest in advanced heart failure. , 1989, Circulation.

[15]  S L Winters,et al.  The prognostic significance of quantitative signal-averaged variables relative to clinical variables, site of myocardial infarction, ejection fraction and ventricular premature beats: a prospective study. , 1989, Journal of the American College of Cardiology.

[16]  K M Kessler,et al.  A biological approach to sudden cardiac death: structure, function and cause. , 1989, The American journal of cardiology.

[17]  B. Pitt,et al.  Predictors of total mortality and sudden death in mild to moderate heart failure. Captopril-Digoxin Study Group. , 1989, Journal of the American College of Cardiology.

[18]  J F Leclercq,et al.  Ambulatory sudden cardiac death: mechanisms of production of fatal arrhythmia on the basis of data from 157 cases. , 1989, American heart journal.

[19]  J. Mccomb,et al.  QT dispersion: an indication of arrhythmia risk in patients with long QT intervals. , 1990, British heart journal.

[20]  G. Diamond,et al.  Fascinating rhythm: a primer on chaos theory and its application to cardiology. , 1990, American heart journal.

[21]  G. Breithardt,et al.  Standards for analysis of ventricular late potentials using high resolution or signal-averaged electrocardiography. A statement by a Task Force Committee between the European Society of Cardiology, the American Heart Association and the American College of Cardiology. , 1991, European heart journal.

[22]  H L Greene,et al.  Mortality and morbidity in patients receiving encainide, flecainide, or placebo. The Cardiac Arrhythmia Suppression Trial. , 1991, The New England journal of medicine.

[23]  E. Prystowsky,et al.  Physiological Substrate for Antidromic Reciprocating Tachycardia: Prerequisite Characteristics of the Accessory Pathway and Atrioventricular Conduction System , 1992, Circulation.

[24]  J. Fleiss,et al.  Predicting arrhythmic events after acute myocardial infarction using the signal-averaged electrocardiogram. , 1992, The American journal of cardiology.

[25]  G. Steinbeck,et al.  A comparison of electrophysiologically guided antiarrhythmic drug therapy with beta-blocker therapy in patients with symptomatic, sustained ventricular tachyarrhythmias. , 1992, The New England journal of medicine.

[26]  J. Brugada,et al.  Right bundle branch block, persistent ST segment elevation and sudden cardiac death: a distinct clinical and electrocardiographic syndrome. A multicenter report. , 1992, Journal of the American College of Cardiology.

[27]  J. Fleiss,et al.  Frequency Domain Measures of Heart Period Variability and Mortality After Myocardial Infarction , 1992, Circulation.

[28]  L. Tavazzi,et al.  Prevalence and Prognostic Significance of Ventricular Arrhythmias After Acute Myocardial Infarction in the Fibrinolytic Era GISSI‐2 Results , 1993, Circulation.

[29]  A. Adgey,et al.  Value of signal-averaged electrocardiography, radionuclide ventriculography, Holter monitoring and clinical variables for prediction of arrhythmic events in survivors of acute myocardial infarction in the thrombolytic era. , 1993, Journal of the American College of Cardiology.

[30]  R. Myerburg,et al.  Sudden Cardiac Death: Epidemiology, Transient Risk, and Intervention Assessment , 1993, Annals of Internal Medicine.

[31]  P. Kudenchuk,et al.  Implantable cardioverter-defibrillator therapy in survivors of out-of-hospital sudden cardiac death without inducible arrhythmias. , 1993, Journal of the American College of Cardiology.

[32]  Recent insights in programmed electrical stimulation for the management of sustained ventricular arrhythmias. , 1994, Current opinion in cardiology.

[33]  D E Ward,et al.  QT Dispersion: Problems of Methodology and Clinical Significance , 1994, Journal of cardiovascular electrophysiology.

[34]  J. Ruskin,et al.  Electrical alternans and vulnerability to ventricular arrhythmias. , 1994, The New England journal of medicine.

[35]  C. Lang,et al.  QT dispersion and sudden unexpected death in chronic heart failure , 1994, The Lancet.

[36]  P. Denes,et al.  Definition of the best prediction criteria of the time domain signal-averaged electrocardiogram for serious arryhthmic events in the postinfarction period , 1995 .

[37]  H V Huikuri,et al.  Dispersion of QT interval in patients with and without susceptibility to ventricular tachyarrhythmias after previous myocardial infarction. , 1995, Journal of the American College of Cardiology.

[38]  M R Franz,et al.  Electrocardiographic indexes of dispersion of ventricular repolarization: an isolated heart validation study. , 1995, Journal of the American College of Cardiology.

[39]  D. D. Bono,et al.  QT dispersion and mortality after myocardial infarction , 1995, The Lancet.

[40]  P C Deedwania,et al.  Amiodarone in patients with congestive heart failure and asymptomatic ventricular arrhythmia. Survival Trial of Antiarrhythmic Therapy in Congestive Heart Failure. , 1995, The New England journal of medicine.

[41]  G. Mela,et al.  Value of programmed ventricular stimulation in predicting sudden death and sustained ventricular tachycardia in survivors of acute myocardial infarction. , 1996, The American journal of cardiology.

[42]  Bertram Pitt,et al.  Effect of d-sotalol on mortality in patients with left ventricular dysfunction after recent and remote myocardial infarction , 1996, The Lancet.

[43]  A. Moss,et al.  Improved survival with an implanted defibrillator in patients with coronary disease at high risk for ventricular arrhythmia. Multicenter Automatic Defibrillator Implantation Trial Investigators. , 1996, The New England journal of medicine.

[44]  R. Gerszten,et al.  What is the risk of sudden cardiac death in patients presenting with hemodynamically stable sustained ventricular tachycardia after myocardial infarction? , 1996, Journal of the American College of Cardiology.

[45]  R J Cohen,et al.  Predicting Sudden Cardiac Death From T Wave Alternans of the Surface Electrocardiogram: , 1996, Journal of cardiovascular electrophysiology.

[46]  D. Levy,et al.  Impact of reduced heart rate variability on risk for cardiac events. The Framingham Heart Study. , 1996, Circulation.

[47]  S. Dubner,et al.  Nonsustained ventricular tachycardia in severe heart failure. Independent marker of increased mortality due to sudden death. GESICA-GEMA Investigators. , 1996, Circulation.

[48]  A. Maggioni,et al.  Prognostic significance of heart rate variability in post-myocardial infarction patients in the fibrinolytic era. The GISSI-2 results. Gruppo Italiano per lo Studio della Sopravvivenza nell' Infarto Miocardico. , 1996, Circulation.

[49]  H. Crijns,et al.  Cost-effectiveness of implantable defibrillator as first-choice therapy versus electrophysiologically guided, tiered strategy in postinfarct sudden death survivors. A randomized study. , 1996, Circulation.

[50]  M Malik,et al.  Distinction between arrhythmic and nonarrhythmic death after acute myocardial infarction based on heart rate variability, signal-averaged electrocardiogram, ventricular arrhythmias and left ventricular ejection fraction. , 1996, Journal of the American College of Cardiology.

[51]  F. Venditti,et al.  Classification of death in antiarrhythmia trials. , 1996, Journal of the American College of Cardiology.

[52]  M. Schoenfeld,et al.  Exploration of the precision of classifying sudden cardiac death. Implications for the interpretation of clinical trials. , 1996, Circulation.

[53]  J. Mason,et al.  Predictors of arrhythmic death and cardiac arrest in the ESVEM trial. Electrophysiologic Study Versus Electromagnetic Monitoring. , 1997, Circulation.

[54]  M. Keller,et al.  A comparison of antiarrhythmic-drug therapy with implantable defibrillators in patients resuscitated from near-fatal ventricular arrhythmias. , 1997, The New England journal of medicine.

[55]  A. Camm,et al.  Randomised trial of effect of amiodarone on mortality in patients with left-ventricular dysfunction after recent myocardial infarction: EMIAT , 1997, The Lancet.

[56]  Bigger Jt,et al.  Prophylactic use of implanted cardiac defibrillators in patients at high risk for ventricular arrhythmias after coronary-artery bypass graft surgery , 1997 .

[57]  R. Cohen,et al.  Electrical alternans during rest and exercise as predictors of vulnerability to ventricular arrhythmias. , 1997, The American journal of cardiology.

[58]  S. Connolly,et al.  Randomised trial of outcome after myocardial infarction in patients with frequent or repetitive ventricular premature depolarisations: CAMIAT , 1997, The Lancet.

[59]  V. Fuster,et al.  Sudden death in coronary artery disease: acute ischemia versus myocardial substrate. , 1997, Circulation.

[60]  H V Huikuri,et al.  Heart rate variability and dispersion of QT interval in patients with vulnerability to ventricular tachycardia and ventricular fibrillation after previous myocardial infarction. , 1997, Journal of the American College of Cardiology.

[61]  K M Kessler,et al.  Frequency of sudden cardiac death and profiles of risk. , 1997, The American journal of cardiology.

[62]  A. Castellanos,et al.  Clinical trials of implantable defibrillators. , 1997, The New England journal of medicine.

[63]  R J Cohen,et al.  T-wave alternans and dispersion of the QT interval as risk stratification markers in patients susceptible to sustained ventricular arrhythmias. , 1998, The American journal of cardiology.

[64]  B M Psaty,et al.  Family history as a risk factor for primary cardiac arrest. , 1998, Circulation.

[65]  S. Priori,et al.  Influence of the genotype on the clinical course of the long-QT syndrome. International Long-QT Syndrome Registry Research Group. , 1998, The New England journal of medicine.

[66]  R. Prescott,et al.  Prospective study of heart rate variability and mortality in chronic heart failure: results of the United Kingdom heart failure evaluation and assessment of risk trial (UK-heart). , 1998, Circulation.

[67]  R J Cohen,et al.  T Wave Alternans as a Predictor of Recurrent Ventricular Tachyarrhythmias in ICD Recipients: Prospective Comparison with Conventional Risk Markers , 1998, Journal of cardiovascular electrophysiology.

[68]  F. Khaja,et al.  Arrhythmogenic right ventricular dysplasia/cardiomyopathy: review for the clinician. , 1998, Progress in cardiovascular diseases.

[69]  A. Castellanos,et al.  Interpretation of outcomes of antiarrhythmic clinical trials: design features and population impact. , 1998, Circulation.

[70]  S. Fisher,et al.  Prevalence and significance of nonsustained ventricular tachycardia in patients with premature ventricular contractions and heart failure treated with vasodilator therapy , 1998 .

[71]  J. Bigger,et al.  Baroreflex sensitivity and heart-rate variability in prediction of total cardiac mortality after myocardial infarction , 1998, The Lancet.

[72]  S. Hohnloser,et al.  Assessment of QT dispersion for prediction of mortality or arrhythmic events after myocardial infarction: results of a prospective, long-term follow-up study. , 1998, Circulation.

[73]  S. Gottlieb,et al.  Effect of beta-blockade on mortality among high-risk and low-risk patients after myocardial infarction. , 1998, The New England journal of medicine.

[74]  A. Camm,et al.  Amiodarone interaction with beta-blockers: analysis of the merged EMIAT (European Myocardial Infarct Amiodarone Trial) and CAMIAT (Canadian Amiodarone Myocardial Infarction Trial) databases. The EMIAT and CAMIAT Investigators. , 1999, Circulation.

[75]  S. Markowitz,et al.  Long-term outcome of patients with unexplained syncope treated with an electrophysiologic-guided approach in the implantable cardioverter-defibrillator era. , 1999, Journal of the American College of Cardiology.

[76]  M. Brodsky,et al.  Relative effectiveness of the implantable cardioverter-defibrillator and antiarrhythmic drugs in patients with varying degrees of left ventricular dysfunction who have survived malignant ventricular arrhythmias. AVID Investigators. Antiarrhythmics Versus Implantable Defibrillators. , 1999, Journal of the American College of Cardiology.

[77]  H V Huikuri,et al.  Measurement of heart rate variability: a clinical tool or a research toy? , 1999, Journal of the American College of Cardiology.

[78]  A. Garfinkel,et al.  Chaos and the transition to ventricular fibrillation: a new approach to antiarrhythmic drug evaluation. , 1999, Circulation.

[79]  A. Auricchio,et al.  New primary prevention trials of sudden cardiac death in patients with left ventricular dysfunction: SCD-HEFT and MADIT-II. , 1999, The American journal of cardiology.

[80]  P Ducimetière,et al.  Predicting sudden death in the population: the Paris Prospective Study I. , 1999, Circulation.

[81]  K. Lee,et al.  A randomized study of the prevention of sudden death in patients with coronary artery disease. Multicenter Unsustained Tachycardia Trial Investigators. , 1999, The New England journal of medicine.

[82]  The implantable cardioverter defibrillator and primary prevention of sudden death: the Multicenter Automatic Defibrillator Implantation Trial and the Coronary Artery Bypass Graft (CABG)-Patch Trial. , 1999, The American journal of cardiology.

[83]  S. Pinski,et al.  Implantable cardioverter-defibrillators. , 1999, The American journal of medicine.

[84]  Riccardo Cappato,et al.  Randomized Comparison of Antiarrhythmic Drug Therapy With Implantable Defibrillators in Patients Resuscitated From Cardiac Arrest The Cardiac Arrest Study Hamburg (CASH) , 2000 .

[85]  B. Maron,et al.  Magnitude of left ventricular hypertrophy and risk of sudden death in hypertrophic cardiomyopathy. , 2000, The New England journal of medicine.

[86]  B. Massie,et al.  Ambulatory ventricular arrhythmias in patients with heart failure do not specifically predict an increased risk of sudden death. PROMISE (Prospective Randomized Milrinone Survival Evaluation) Investigators. , 2000, Circulation.

[87]  S. Hohnloser,et al.  Predictive value of T-wave alternans for arrhythmic events in patients with congestive heart failure , 2000, The Lancet.

[88]  R. Myerburg,et al.  Sudden Cardiac Death: Exploring the Limits of Our Knowledge , 2001, Journal of cardiovascular electrophysiology.